Impact of the TLR4 agonist BECC438 on a novel vaccine formulation against Shigella spp.
Lu T, Das S, Howlader DR, Jain A, Hu G, Dietz ZK, Zheng Q, Ratnakaram SSK, Whittier SK, Varisco DJ, Ernst RK, Picking WD, Picking WL.
Lu T, et al. Among authors: howlader dr.
Front Immunol. 2023 Sep 6;14:1194912. doi: 10.3389/fimmu.2023.1194912. eCollection 2023.
Front Immunol. 2023.
PMID: 37744341
Free PMC article.